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PROLONGED CARDIOPULMONARY BYPASS FOR SEVERE DRUG INTOXICATION
Miralem Pasic, MD, PhD, FETCS, Evgenij Potapov, MD, Hermann Kuppe, MD, PhD and Roland Hetzer, MD, PhD,
Berlin, Germany
Cardiopulmonary bypass (CPB), a standard procedure in
cardiac surgery, has been only exceptionally used for treat-
ment of severe drug intoxication, with mostly poor results.1-5
We report on the successful use of a very long duration of
CPB for severe intoxication with the antiarrhythmic drug praj-
malium.
Clinical summary. A 25-year-old hospitalized woman took
16 tablets (320 mg) of prajmalium bitartrate (Neo-Gilurytmal)
with the possible intention of committing suicide. The first
cardiac manifestation was a very short period of brady-
arrhythmia, followed by electromechanical dissociation and
ventricular fibrillation. The estimated interval between drug
intake and the beginning of the symptoms was between 10
and 45 minutes. The intractable electrical and hemodynamic
instabilities were refractory to all conventional therapies
including several attempts to terminate ventricular fibrillation
by electrical defibrillation. The patient was intubated, venti-
lated, and transferred to the operating room while undergoing
external manual heart massage. Standard normothermic CPB
was established through a median sternotomy with cannula-
tion of the ascending aorta and the right atrium. The total
time from the beginning of the cardiopulmonary resuscitation
to the initiation of CPB was 45 minutes. During CPB, direct
cardiac electrical defibrillation was undertaken every 10 min-
utes to terminate ventricular fibrillation but all attempts
failed. After 55 minutes of CPB, ventricular fibrillation con-
verted spontaneously into sinus rhythm. Elevations of the ST
interval and very high T waves were seen for the following 4
hours, and the electrocardiographic findings improved there-
after. Since there is no specific treatment for intoxication with
this particular drug, we added several general therapeutic
measures such as gastric lavage, forced diuresis (in total 11 L
during CPB), ultrafiltration (37 L), and hemoabsorption with
a charcoal filter inserted in the CPB circuit. After 6 hours of
reperfusion, the first attempt at discontinuation of CPB was
undertaken but it failed to establish stable hemodynamics.
The predominant cause was right-sided heart failure, which
appeared despite administration of inotropic support, inhala-
tion of nitric oxide for lowering the pulmonary vascular resis-
tance, and implantation of an intra-aortic balloon counterpul-
sation device. The hemodynamic instability was stressed by
initiation of intermittent ventricular fibrillation with the heart
volume loaded. It was only after a total of 1000 minutes (16
hours 40 minutes) of reperfusion that a persistent stable
hemodynamic situation was achieved after cessation of CPB.
The duration of reperfusion necessary to achieve optimal
hemodynamics correlated well with the retrospectively esti-
mated half-life of the ingested drug. Assessed by its plasma
concentrations, the half-life of prajmaline was 16 hours 43
minutes, almost exactly the length of CPB. The postoperative
course was uneventful except for a prolonged neurologic
recovery. During her hospital stay, she had ataxic walk and
expressed disturbances of cognitive functions, affect instabil-
ity, and mood disorder. On the 35th postoperative day she
was discharged to a neuropsychiatric rehabilitation facility.
Echocardiography showed good functioning of the heart with
only slightly reduced contractility of the right ventricle.
Comment. Prolonged CPB was the only therapeutic solu-
tion for resuscitation because the patient needed more than 16
hours of reperfusion to achieve recovery and stabilization of
the mechanical and electrical function of the heart. We used
conventional CPB, which allowed for excellent heart venting
and prevented the highly dangerous risk of right and left ven-
tricular dilation. A possible alternative is percutaneous CPB,
which can be instituted through femoral vessels. This proce-
dure does not require that the chest be opened, but it includes
several important disadvantages such as possible dangerous
distention of the cardiac ventricles, damage of the peripheral
vessels, ischemic leg complications, and hemorrhage. In
some instances it cannot be applied because of atherosclerot-
ic vascular changes or a small diameter of the vessels.
This report shows that emergency CPB may be the only
therapeutic option to establish stable hemodynamics in
patients who do not respond to conventional resuscitation
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efforts. Prolonged reperfusion during CPB enables good
recovery of the heart and may improve detoxification by
increased elimination of an overdosed drug. This therapeutic
option should be considered in patients with severe drug
intoxication and hemodynamic instability despite prolonged
resuscitation.
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